Simcere Pharmaceutical Group. (SCR) Earnings
|
Expand Research on SCR
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -23.8% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | N/A |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/9/13 | Q113 | RMB0.56 | N/A | N/A | RMB528.73M | RMB487.61M | N/A | Details | |||
3/7/13 | Q412 | -$0.06 | $0.00 | -$0.06 | $86.7M | $88.06M | N/A | Details | |||
8/9/11 | Q211 | $0.21 | $0.13 | +$0.08 | $84.4M | $90.61M | N/A | Details | |||
11/15/12 | Q312 | $0.07 | $0.07 | $0.00 | $83.8M | $85.72M | N/A | Details | |||
8/10/12 | Q212 | $0.08 | $0.10 | -$0.02 | $83.2M | $86.83M | N/A | Details | |||
3/7/12 | Q411 | $0.12 | $0.10 | +$0.02 | $81.2M | $86.35M | N/A | Details | |||
8/13/13 | Q213 | $0.03 | $0.12 | -$0.09 | $78.7M | $91.58M | N/A | Details | |||
11/14/11 | Q311 | $0.10 | $0.15 | -$0.05 | $78.5M | $94.66M | N/A | Details |